TC
BLFS icon

Trium Capital’s BioLife Solutions BLFS Stock Holding History

Trium Capital’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.96M Buy
+76,232
New +$2.58M 3.73% 5

Other funds holding BLFS

PM
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return
PWMA
Pension & Wealth Management Advisors Waltham, Massachusetts $441M AUM 9.69% 1-Year Est. Return
UPWML
UMB Private Wealth Management, LLC Kansas City, Missouri $103M AUM

Trium Capital's BLFS Position: Q3 2026 in Review

Trium Capital opened a new position in BioLife Solutions (BLFS) in Q3 2026: 76,232 shares worth $2.96M. The stake represents 3.73% of the portfolio and ranks #5 among its holdings.

17 funds tracked by Wall St. Rank hold BLFS as of Q3 2026.

  • Trium Capital held 76,232 shares of BioLife Solutions worth $2.96M as of Q3 2026.
  • BioLife Solutions was a new Trium Capital position in Q3 2026.
  • BioLife Solutions made up 3.73% of Trium Capital's portfolio in Q3 2026, its #5 holding.
  • 17 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2026.

Based on Trium Capital's 13F filing for Q3 2026, filed 16 Oct 2026.